Evidence map›Paper›PMID 28223486›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood-brain barrier impairment.

Mario J Aragon, Lauren Topper, Christina R Tyler, Bethany Sanchez, Katherine Zychowski, Tamara Young, Guy Herbert, Pamela Hall, Aaron Erdely, Tracy Eye and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Air Pollution and Dementia: A Systematic Review.Journal of Alzheimer's disease : JAD · 2019
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Mario J AragonDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Lauren TopperDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Christina R TylerDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Bethany SanchezDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Katherine ZychowskiDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Tamara YoungDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Guy HerbertDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Pamela HallDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131.
Aaron ErdelyPathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV 26505.
Tracy EyePathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV 26505.
Lindsey BishopPathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV 26505.
Samantha A SaundersDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298.
Pretal P MuldoonDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298.
Andrew K OttensDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298 akottens@vcu.edu mcampen@salud.unm.edu.
Matthew J CampenDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131; akottens@vcu.edu mcampen@salud.unm.edu.
University of New Mexico · USNational Institute for Occupational Safety and Health · USVirginia Commonwealth University · US

Funding

FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Mechanisms of Vascular Toxicity from Inhaled ToxicantsR01ES014639 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J · 2008 to 2023
$6.7M
MINORITY INSTITUTIONAL RESEARCH TRAINING PROGRAM (T32)T32HL007736 · NHLBI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI RESTA, THOMAS C · 1993 to 2025
$6.5M
VCU Bridges to the Baccalaureate: From Dream to GoalR25GM102795 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHU, SHIJIAN, GOLDING, SARAH ELIZABETH · 2013 to 2022
$2.6M
Systemic Health Implications of Occupational Nanomaterial ExposureR01OH010828 · OH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, OTTENS, ANDREW K · 2015 to 2018
$1.9M
Environmental Exposure Perturbs Mitochondrial Mechanisms during NeurodevelopmentR21ES023060 · NIEHS · VIRGINIA COMMONWEALTH UNIVERSITY · PI OTTENS, ANDREW K · 2014 to 2015
$398k
Enhancement of Coronary Constriction by Volatile Organic Air ToxicsR56ES014639 · NIEHS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J · 2013 to 2013
$148k
NHLBI NIH HHS T32 HL007736NIEHS NIH HHS R01 ES014639NIEHS NIH HHS R21 ES023060NIEHS NIH HHS R56 ES014639NIGMS NIH HHS K12 GM088021NIGMS NIH HHS R25 GM102795NIOSH CDC HHS R01 OH010828
6 · The paper itself

Abstract

Pulmonary exposure to multiwalled carbon nanotubes (MWCNTs) causes indirect systemic inflammation through unknown pathways. MWCNTs translocate only minimally from the lungs into the systemic circulation, suggesting that extrapulmonary toxicity may be caused indirectly by lung-derived factors entering the circulation. To assess a role for MWCNT-induced circulating factors in driving neuroinflammatory outcomes, mice were acutely exposed to MWCNTs (10 or 40 µg/mouse) via oropharyngeal aspiration. At 4 h after MWCNT exposure, broad disruption of the blood-brain barrier (BBB) was observed across the capillary bed with the small molecule fluorescein, concomitant with reactive astrocytosis. However, pronounced BBB permeation was noted, with frank albumin leakage around larger vessels (>10 µm), overlain by a dose-dependent astroglial scar-like formation and recruitment of phagocytic microglia. As affirmed by elevated inflammatory marker transcription, MWCNT-induced BBB disruption and neuroinflammation were abrogated by pretreatment with the rho kinase inhibitor fasudil. Serum from MWCNT-exposed mice induced expression of adhesion molecules in primary murine cerebrovascular endothelial cells and, in a wound-healing in vitro assay, impaired cell motility and cytokinesis. Serum thrombospondin-1 level was significantly increased after MWCNT exposure, and mice lacking the endogenous receptor CD36 were protected from the neuroinflammatory and BBB permeability effects of MWCNTs. In conclusion, acute pulmonary exposure to MWCNTs causes neuroinflammatory responses that are dependent on the disruption of BBB integrity.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAdministration, InhalationAnimalsAstrocytesBlood-Brain BarrierBrainCD36 AntigensCell MovementDrug CarriersEncephalitisEndothelial CellsFluoresceinFluorescent DyesLungMiceNanotubes, Carbon1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineCD36 AntigensDrug CarriersfasudilFluoresceinFluorescent DyesNanotubes, CarbonProtein Kinase Inhibitorsrho-Associated KinasesThrombospondin 1thrombospondin-1, humanblood-brain barriermicrogliamultiwalled carbon nanotubenanoparticlethrombospondin-1

Identifiers

PMID28223486
PMCPMC5347541
OpenAlexW2591366418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.